Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo: Induction by tumor necrosis factor-α and lipopolysaccharide

Journal of Clinical Investigation

Volumn 97, Issue 1, 1996, Pages 37-46

  Samad, Fahumiya ^a   Yamamoto, Koji ^a   Loskutoff, David J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

3T3 cells; Endotoxin; Obesity; Thrombosis; TNF

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY MECHANISM; THROMBOSIS;

3T3 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030050952     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118404     Document Type: Article

References (49)

1. Sprengers, E. D., and C. Kluft. 1987. Plasminogen activator inhibitors. Blood 69.381-387.
2. Astrup, T. 1978. Fibrinolysis: an overview. In Progress in Chemical Fibrinolysis and Thrombolysis. J. F. Davidson, R. M. Rowan, M. M. Samama, and P C. Desnoyers, editors. Raven Press, New York. 1-57
3. Vassalli, J. D., A. P. Sappino, and D. Belin 1991. The plasminogen activator/plasmin system. J. Clin. Invent 88:1067-1072.
4. Loskutoff, D. J. 1991. Regulation of PAI-1 gene expression Fibrinolysis 5:197-206.
5. Dawson, S , and A. Henney. 1992 The status of PAl-1 as a risk factor for arterial and thrombotic disease, a review. Atherosclerosis. 95:105-117.
6. Dieval, J., G. Nguyen, S. Gross, J. Delobel, and E. K. O. Kruithof 1991. A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1. Blood 77.528-532.
7. Lee, M. H., E. Vosburgh, K Anderson, and J. McDonagh. 1993. Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding. Blood. 81:2357-2362.
8. Schleef, R. R., D. L. Higgins, E. Pillemer, and J. J Levitt. 1989. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. J. Clin. Invest. 83:1747-1752.
9. Francis, R. B., Jr., H. Liebman, S. Koehler, and D. I. Feinstein. 1986. Accelerated fibrinolysis in amyloidosis. Specific binding of tissue plasminogen activator inhibitor by an amyloidogenic monoclonal IgG. Blood 68.333a. (Abstr.)
10. Fay, W. P., A. D. Shapiro, J. L. Shih, R. R. Schleef, and D. Ginsburg. 1992. Complete deficiency of plasminogen-activator inhibitor type 1 due to a frameshift mutation. N. Engl. J. Med 327:1729-1733
11. Carmeliet, P., J. M. Stassen, L. Schoonjans, B. Ream, J. J. Van den Oord. M. De Mol, R. C. Mulligan, and D. Collen. 1993. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J. Clin. Invest. 92:2756-2760.
12. Colucci, M., J A Paramo, and D. Collen. 1985. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J. CIm. Invest. 75:818-824.
13. Kruithof, E. K. O., C. Tran-Thang, A Gudinchet, J. Hauert, G. Nicoloso, C. Genton, H. Welti, and F. W. Bachmann 1987. Fibrinolysis in pregnancy. A study of plasminogen activator inhibitors. Blood 69:460-466.
14. Lupu, F., G. E. Bergonzelli, D. A. Heim, E. Cousin, C. Y Genton, F. Bachmann, and E. K. O. Kruithof. 1993. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler. Thromb. 13:1090-1100
15. Schneiderman, J., M S. Sawdey, M R. Keeton, G. M Bordin, E. F. Bernstein, R. B. Dilley, and D. J. Loskutoff. 1992. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad. Sci. USA. 89:6998-7002
16. Larsson, B. 1991. Obesity, fat distribution and cardiovascular disease. Int. J Obes. 15:53-57.
17. Björntorp, P. 1992. Abdominal fat distribution and disease: an overview of epidemiological data. Ann Med. 24.15-18.
18. DeFronzo, R. A., and E. Ferrannini 1991. Insulin resistance: a multifaceted syndrome responsible for NIDDM. obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14:173-194.
19. McGill, J. B . D. J. Schneider, C. L. Arfken, C. L. Lucore, and B. E. Sobel. 1994. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes. 43:104-109.
20. Potter van Loon, B. J., C. Kluft, J. K Radder, M. A. Blankenstein. and A. E. Memders. 1993. The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metab. Clin. Exp 42:945-949.
21. Legnani, C., M. Maccaferri, P. Tonini, A. Cassio, E. Cacciari, and S. Coccheri. 1988. Reduced fibrinolytic response in obese children: associations with high baseline activity of the fast acting plasminogen activator inhibitor (PAI-1). Fibrinolysis 2:211-214.
22. Vague, P., I. Juhan-Vague, V. Chabert, M. C Alessi, and C. Atlan. 1989. Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women. Metab. Clin Exp 38:913-915.
23. Takada, Y , T. Urano, I. Watanabe, A. Taminato, T. Yoshimi, and A. Takada. 1993. Changes in fibrinolytic parameters in male patients with type 2 (non-insulin-dependent) diabetes mellitus. Thromb. Res. 71:405-415.
24. Juhan-Vague, I., B. Moerman, F. De Cock, M F. Aillaud, and D. Collen. 1984 Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions Thromb Res. 33: 523-530.
25. Sundell, I. B , T K. Nilsson, G. Hallmans, G. Hellmans, and G. H. Dahlen. 1989. Interrelationship between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardio-vascular risk factors in a North Swedish population Atherosclerosis 80:9-16.
26. Primrose, J. N., J. A. Davies, C. R. M. Prentice, R. Hughes, and D. Johnston 1992 Reduction in factor VII. fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity. Thromb. Haemostasis. 68:396-399.
27. Sawdey, M., and D J. Loskutoff. 1991. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β. J. Clin. Invest 88:1346-1353.
28. Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman. 1993. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science (Wash. DC). 259:87-91.
29. van Hinsbergh, V. W , T. Kooistra, E. A. van den Berg, H. M. Princen, W. Fiers, and J. J. Emeis. 1988. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood. 72:1467-1473.
30. Kooistra, T. 1990. The use of cultured human endothelial cells and hepatocytes as an in vitro model system to study modulation of endogenous fibrinolysis. Fibrinolysis. 4:33-39.
31. Bone, R C. 1991. The pathogenesis of sepsis. Ann. Intern Med 115: 457-469.
32. Chomczynski, P , and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thyiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
33. Sawdey, M., T. J. Podor, and D. J. Loskutoff. 1989. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells: induction by transforming growth factor-β, lipopolysaccharide, and tumor necrosis factor-α. J. Biol Chem. 264:10396-10401.
34. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
35. Wang, A. M., M. V. Doyle, and D. F. Mark. 1989. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl Acad. Sci. USA. 86:9717-9721.
36. Keeton, M., Y Eguchi, M. Sawdey, C. Ahn, and D. J. Losfcutoff. 1993. Cellular localization of type 1 plasminogen activator inhibitor mRNA and protein in murine renal tissue. Am. J Pathol. 142:59-70
37. Reik, L M., S. M. Maines, D. E. Ryan, W. Levin, S. Bandiera, and P. E. Thomas. 1987. Isolation of monoclonal antibodies against cytochrome P450 isozymes. J. Immunol Methods. 100:123-130.
38. Rodbell, M. 1964. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 239:375-380.
39. Green, H., and O. Kehinde. 1975. An established preadipose cell Line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell. 5 19-27.
40. Nachman, R L., K. A. Hajjar, R. L. Silverstein, and C. A. Dinarello. 1986. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J. Exp. Med. 163.1595-1600.
41. Remacle, C., and F. Gregoire. 1992. Cellular and molecular biology in the study of the physiopathology of obesity. Acta Clin Belg. Suppl. 14:3-12.
42. Hotamisligil, G S., P. Arner, J. F. Caro, R. L Atkinson, and B. M. Spiegelman. 1995. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin. Invest. 95:2409-2415.
43. Kern, P. A., M. Saghizadeh, J. M. Ong, R. J. Bosch, R. Deem, and R. B. Simsolo. 1995 The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin. Invest. 95:2111-2119.
44. Saks, S., and M. Rosenbium. 1992. Recombinant human TNF-alpha: preclinical studies and results from clinical trials. Immunol Ser. 56:567-587.
45. Sheehan, K C F., N. H. Ruddle, and R. D. Schreiber. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J. Immunol. 142:3884-3893.
46. Eguchi, Y., M. Keeton, M. Sawdey, and D. J. Loskutoff. 1991. Endotoxin induces the expression of type 1 plasminogen activator inhibitor (PAI-1) protein and mRNA by endothelial cells in mouse tissues in vivo. Thromb. Haemostosis. 65:652a. (Abstr.)
47. Fearns, C., T. Thinnes, K. Roegner, and D. J. Loskutoff. 1993. Kinetics of induction of PAI-1 gene expression on liver endothelial cells and hepatocytes by lipopolysaccharide (LPS). Thromb. Haemostasis. 69:757a. (Abstr.)
48. Knudsen, B. S., P. C. Hapel, and R. L. Nachman. 1987. Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. J. Clin. Invest. 80:1082-1089.
49. Mimuro, J , R. R. Schleef, and D. J. Loskutoff. 1987. Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor. Blood. 70:721-728.